Cytochrome P450 1B1 promotes cancer cell survival via specificity protein 1 (Sp1)-mediated suppression of death receptor 4
Authors:
- 23 February 2018
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health, Part A
- Vol. 81 (9) , 278-287
Abstract
Cytochrome P450 1B1 (CYP1B1), a well-known oncogene, has garnered wide attention because of its tumor-specific expression pattern and actions as a carcinogenic factor. Although CYP1B1 might play a crucial role in carcinogenesis, the detailed molecular mechanisms underlying oncogenic involvement in cancer development remain unclear. The present study investigated the manner in which CYP1B1 promotes survival of various cancer cells. Treatment with 2,2ˊ,4,6ˊ-tetramethoxystilbene (TMS), a specific CYP1B1 inhibitor, significantly inhibited cell viability in human breast cancer and leukemia cell lines, including MCF-7, MDA-MB-231, HL-60, and U937 cells. In order to characterize the cellular functions of CYP1B1 associated with cancer cell survival, the relationship between this oncogene and death receptor 4 (DR4) was determined. Following induction or inhibition of CYP1B1, mRNA and protein expression levels of DR4 were measured, and this oncogene was found to significantly repress DR4 mRNA and protein expression. Further, the suppression of DR4 by CYP1B1 was restored with 5-aza-2ˊ-deoxycytidine (5-aza-dC), a DNA methyltransferase inhibitor, indicating that DNA methylation may be involved in CYP1B1-mediated DR4 inhibition. Methylation-specific polymerase chain reaction (PCR) in CYP1B1-overexpressed HL-60 cells revealed that this oncogene induced hypermethylation on DR4 promoter. Interestingly, data showed that DR4 suppression of CYP1B1 is mediated by the DNA-binding ability of specificity protein 1 (Sp1). These findings suggest that CYP1B1 promotes cancer cell survival through involvement of DNA methylation-mediated DR4 inhibition and that Sp1 may act as key mediator required for oncogenic action.Keywords
This publication has 41 references indexed in Scilit:
- Death Receptor Pathway Activation and Increase of ROS Production by the Triple Epigenetic Inhibitor UVI5008Molecular Cancer Therapeutics, 2011
- A decade of exploring the cancer epigenome — biological and translational implicationsNature Reviews Cancer, 2011
- Dysregulation of p53/Sp1 Control Leads to DNA Methyltransferase-1 Overexpression in Lung CancerCancer Research, 2010
- Functional Significance of CytochromeP450 1B1 in Endometrial CarcinogenesisCancer Research, 2009
- Potent inhibition of human cytochrome P450 1B1 by tetramethoxystilbeneToxicology Letters, 2009
- The TRAIL apoptotic pathway in cancer onset, progression and therapyNature Reviews Cancer, 2008
- EUKARYOTIC CYTOSINE METHYLTRANSFERASESAnnual Review of Biochemistry, 2005
- Contribution of Epigenetic Silencing of Tumor Necrosis Factor–Related Apoptosis Inducing Ligand Receptor 1 (DR4) to TRAIL Resistance and Ovarian CancerMolecular Cancer Research, 2005
- Apo2L/TRAIL and its death and decoy receptorsCell Death & Differentiation, 2003
- Targeting death and decoy receptors of the tumour-necrosis factor superfamilyNature Reviews Cancer, 2002